Hannah Yang

4PUBLICATIONS

11CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Dec 18, 2025

Elevated antidrug antibodies against atezolizumab and associated clinical outcomes in advanced non-small-cell lung cancer.

Miran Jang, Chan Kim, So Jung Kong

|Oct 22, 2024

Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer.

Won Suk Lee, Seung Joon Lee, Hye Jin Lee

|Sep 25, 2023

PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis.

Eun-Jin Go, Hannah Yang, Seung Joon Lee

|Jun 29, 2023

Systemic Delivery of a STING Agonist-Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis.

Eun-Jin Go, Hannah Yang, Wooram Park

Pageof 1

Frequent Collaborators

4 joint publications

Hong Jae Chon

4 joint publications

Chan Kim

3 joint publications

Won Suk Lee

1 joint publications

Eun-Jin Go

1 joint publications

Wooram Park

1 joint publications

Dong Keun Han

1 joint publications

Dong Guk Park

1 joint publications

Miran Jang

1 joint publications

So Jung Kong

1 joint publications

Ho Yun Lee

Frequent Collaborators

4 joint publications

Hong Jae Chon

4 joint publications

Chan Kim

3 joint publications

Won Suk Lee

1 joint publications

Eun-Jin Go